Loading...
Loading...
Browse all stories on DeepNewz
VisitHow many additional patients will Osaka treat with iPSCs for LSCD by end of 2025?
0-4 • 25%
5-9 • 25%
10-14 • 25%
15 or more • 25%
Official reports or announcements from Osaka University
Osaka University Researchers Restore Vision in Four Patients with Limbal Stem Cell Deficiency Using Stem Cells
Nov 9, 2024, 02:36 PM
Researchers from Osaka University have achieved a significant breakthrough in treating blindness caused by limbal stem cell deficiency (LSCD) using induced pluripotent stem cells (iPSCs). In a first-of-its-kind interventional study conducted in Japan, the team performed corneal transplant surgery on four patients, with promising results. The study, which was a single-arm, open-label trial, demonstrated rapid vision improvement in all patients post-transplant, with their improved vision remaining stable over time. Notably, only one patient experienced a decline in vision during the initial year following the procedure. This innovative approach marks a pivotal advancement in regenerative medicine and offers new hope for individuals suffering from LSCD.
View original story
0-5 patients • 25%
6-10 patients • 25%
11-15 patients • 25%
More than 15 patients • 25%
Yes • 50%
No • 50%
Less than 50 • 25%
50 to 199 • 25%
200 to 499 • 25%
500 or more • 25%
0-1 • 25%
2-5 • 25%
6-10 • 25%
More than 10 • 25%
0 countries • 25%
1-2 countries • 25%
3-4 countries • 25%
5 or more countries • 25%
Parkinson's Disease • 25%
Heart Disease • 25%
Spinal Cord Injury • 25%
Other • 25%
Yes • 50%
No • 50%
0 companies • 25%
1-2 companies • 25%
3-4 companies • 25%
5 or more companies • 25%
Yes • 50%
No • 50%
Less than 100 patients • 25%
100 to 500 patients • 25%
501 to 1000 patients • 25%
More than 1000 patients • 25%
0-10 patients • 25%
11-20 patients • 25%
21-30 patients • 25%
More than 30 patients • 25%
76-100% • 25%
0-25% • 25%
26-50% • 25%
51-75% • 25%